Peritumoral injections of interleukin 2 induce tumour regression in metastatic malignant melanoma.
Gutwald
J G
JG
Groth
W
W
Mahrle
G
G
D000368:Aged; D006801:Humans; D015552:Injections, Intralesional; D007376:Interleukin-2 / Q000008:administration & dosage*; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000628:therapy*
D007376:Interleukin-2; D011994:Recombinant Proteins